Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/6341
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhang, Mingjie-
dc.contributor.authorDong, Xiaocong-
dc.contributor.authorHuang, Zihui-
dc.contributor.authorLi, Xue-
dc.contributor.authorZhao, Yue-
dc.contributor.authorWang, Yingyao-
dc.contributor.authorZhu, Huilian-
dc.contributor.authorFang, Aiping-
dc.contributor.authorGiovannucci, Edward L.-
dc.date.accessioned2024-09-25T03:12:01Z-
dc.date.available2024-09-25T03:12:01Z-
dc.date.issued2023-07-15-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/6341-
dc.description.abstractABSTRACT This umbrella review aims to provide a systematic and comprehensive overview of current evidence from prospective studies on the diverse health effects of cheese consumption. We searched PubMed, Embase, and Cochrane Library to identify meta-analyses/pooled analyses of prospective studies examining the association between cheese consumption and major health outcomes from inception to August 31, 2022. We reanalyzed and updated previous meta-analyses and performed de novo meta-analyses with recently published prospective studies, where appropriate. We calculated the summary effect size, 95% prediction confidence intervals, between-study heterogeneity, small-study effects, and excess significance bias for each health outcome. We identified 54 eligible articles of meta-analyses/pooled analyses. After adding newly published original articles, we performed 35 updated meta-analyses and 4 de novo meta-analyses. Together with 8 previous meta-analyses, we finally included 47 unique health outcomes. Cheese consumption was inversely associated with all-cause mortality (highest compared with lowest category: RR ¼ 0.95; 95% CI: 0.92, 0.99), cardiovascular mortality (RR ¼ 0.93; 95% CI: 0.88, 0.99), incident cardiovascular disease (CVD) (RR ¼ 0.92; 95% CI: 0.89, 0.96), coronary heart disease (CHD) (RR ¼ 0.92; 95% CI: 0.86, 0.98), stroke (RR ¼ 0.93; 95% CI: 0.89, 0.98), estrogen receptor-negative (ER) breast cancer (RR ¼ 0.89; 95% CI: 0.82, 0.97), type 2 diabetes (RR ¼ 0.93; 95% CI: 0.88, 0.98), total fracture (RR ¼ 0.90; 95% CI: 0.86, 0.95), and dementia (RR ¼ 0.81; 95% CI: 0.66, 0.99). Null associations were found for other outcomes. According to the NutriGrade scoring system, moderate quality of evidence was observed for inverse associations of cheese consumption with all-cause and cardiovascular mortality, incident CVD, CHD, and stroke, and for null associations with cancer mortality, incident hypertension, and prostate cancer. Our findings suggest that cheese consumption has neutral to moderate benefits for human health. Keywords: cheese consumption, umbrella review, updated meta-analyses, all-cause mortality, cardiovascular disease, cancer, fracture, metabolic diseaseen_US
dc.language.isoenen_US
dc.publisherAdvances in Nutritionen_US
dc.subjectcheese consumption,en_US
dc.subjectumbrella review,en_US
dc.subjectupdated meta-analyses,en_US
dc.subjectall-cause mortality,en_US
dc.subjectcardiovascular disease,en_US
dc.subjectcancer,en_US
dc.subjectfracture,en_US
dc.subjectmetabolic diseaseen_US
dc.titleCheese consumption and multiple health outcomes: an umbrella review and updated meta-analysis of prospective studiesen_US
dc.typeArticleen_US
Appears in Collections:VOL 14 No 5 2023

Files in This Item:
File Description SizeFormat 
15. Cheese-consumption-and-multiple-health-outcomes--a.pdf3.04 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.